Aditya Juloori, MD

A variety of treatment options in ES NSCLC are explored by key opinion leaders.

The panel discusses a variety of clinical trials and the impact on patient treatment in early stage NSCLC.

Panelists discuss the utilization of testing and multidisciplinary approaches for testing.

Medical experts discuss a specific case for a patient diagnosed with stage IIIB NSCLC.

Despite limited data comparing stereotactic body radiation therapy to standard or hypofractionated radiotherapy with regards to long-term clinical outcomes and toxicity profiles, the data are promising and appropriately selected patients can be offered such an approach off-protocol.